Damora Therapeutics (DMRA) Shareholder's Equity Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.62% |
| Dec 31, 2025 | 57.31% |
| Sep 30, 2025 | -52.07% |
| Jun 30, 2025 | -49.50% |
| Mar 31, 2025 | -48.66% |
| Dec 31, 2024 | -48.69% |
| Sep 30, 2024 | -45.54% |
| Jun 30, 2024 | -44.96% |
| Mar 31, 2024 | -43.06% |
| Dec 31, 2023 | -41.97% |
| Sep 30, 2023 | 34.03% |
| Jun 30, 2023 | 36.25% |
| Mar 31, 2023 | 38.44% |
| Dec 31, 2022 | 42.08% |
| Sep 30, 2022 | 52.02% |